about
Perspectives for immunotherapy: which applications might achieve an HIV functional cure?Rational combinations of immunotherapeutics that target discrete pathways.IL-15 trans-presentation regulates homeostasis of CD4(+) T lymphocytes.Characterization and favorable in vivo properties of heterodimeric soluble IL-15·IL-15Rα cytokine compared to IL-15 monomer.Genome-wide association study identifies shared risk loci common to two malignancies in golden retrievers.A good manufacturing practice method to ex vivo expand natural killer cells for clinical use.HIV-1 latency: an update of molecular mechanisms and therapeutic strategies.The antileukemic potential of natural killer cells.Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy.Biological Response Modifier in Cancer Immunotherapy.Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.Dual Roles of IL-27 in Cancer Biology and Immunotherapy.Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use.Recombinant human heterodimeric IL-15 complex displays extensive and reproducible N- and O-linked glycosylation.IL-15 is decreased upon CsA and FK506 treatment of acute rejection following heart transplantation in mice.Intraocular cytokines imbalance in congenital cataract and its impact on posterior capsule opacification.Inflammaging in cervical and lumbar degenerated intervertebral discs: analysis of proinflammatory cytokine and TRP channel expression.Purification of inclusion bodies using PEG precipitation under denaturing conditions to produce recombinant therapeutic proteins from Escherichia coli.Effect of Aging on NK Cell Population and Their Proliferation at Ex Vivo Culture Condition
P2860
Q28078726-4151535C-96F2-4AF4-A619-2473E00CB381Q33606144-37647BE5-CB74-4365-9225-B2623690BDBBQ33858357-A998D4BD-B2B7-4AB8-A1F0-574C550C986AQ34708192-CF2295C3-436E-4994-B8D5-069202912F7EQ35099091-8D0459F1-F036-4F97-9082-B2B46C3EF12CQ36187369-6C2D7796-51C7-4E10-A0AE-727463B0C92BQ38204866-FD2AF56E-294F-4BFC-B563-AF0FCC09C3E1Q38773351-68E95B53-9BAF-4975-B3B0-B3EE84919A3EQ38793339-89F6B3CA-E54C-425F-A100-BD2B92898FFDQ38848213-A2016ED2-4AC1-4DAB-8E60-DD4FD0C83897Q39015531-B3ADC842-2BF8-4C6B-90EC-8C015538F5BDQ39158943-A62B138B-02D2-4E47-B338-3DDE69A0560FQ40102608-0D8D219A-65BA-4F38-8429-C39A7D6B9058Q41127818-6F7DCF18-9EAC-4600-8913-298BA9F21FAAQ43012897-9AF3ECEC-76C2-4DFE-8BA1-9FCE57335502Q47858879-D6C58CCA-2B9B-4D13-8363-9E8DFF30660DQ50076665-6A88A52B-5C7B-43AC-887F-EFA62AC50BFCQ50740306-AB72AD90-0679-41F2-8A32-0BBFB5F43270Q58802999-A1786773-AEBB-4A19-A599-F464CECD6053
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immunotherapeutic applications of IL-15.
@en
type
label
Immunotherapeutic applications of IL-15.
@en
prefLabel
Immunotherapeutic applications of IL-15.
@en
P2093
P2860
P356
P1433
P1476
Immunotherapeutic applications of IL-15.
@en
P2093
Anna Maria Orengo
Bruno Azzarone
Michela Croce
Silvano Ferrini
P2860
P304
P356
10.2217/IMT.12.92
P577
2012-09-01T00:00:00Z